Coverage
-
July 22, 2013
A Delaware federal judge on Monday ruled that Mylan Pharmaceuticals Inc. infringed three patents for Cephalon Inc.'s cancer painkiller drug Fentora, saying the former company's proposed generic version of the drug includes components covered by the patents.
1 other articles on this case.
View all »